Becker's Healthcare September 13, 2024
Erica Carbajal

Tampa, Fla.-based Moffitt Cancer Center and drugmaker AstraZeneca are collaborating to accelerate the development of CAR-T cell and T cell receptor therapies.

“We are excited to collaborate with AstraZeneca to push the boundaries of what’s possible in cancer treatment,” Patrick Hwu, MD, Moffitt’s president and CEO, said in a Sept. 13 news release. “By combining our clinical expertise with AstraZeneca’s...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Health System / Hospital, Partnerships, Pharma / Biotech, Provider, Trends
Pharma Pulse 3/14/25: Navigating Internal Constraints and Uncertainty, Health Plan Support During Natural Disasters & more
New AI model can estimate a person's true biological age from five drops of blood
Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal
FDA Approves First Biosimilar to Omalizumab
Zealand Pharma, Roche Reach Potential $5.3 Billion Deal to Develop Petrelintide for Weight Management

Share This Article